Gene · 5903
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis for a nucleoporin exportin complex between RanBP2, SUMO1-RanGAP1, the E2 Ubc9, Crm1 and the Ran GTPase. | Nat Commun | 2025 | 40640138 | PubTator, text mining | PubMed |
| The Genetic Landscape of Acute Necrotizing Encephalopathy: Insights Into the Possible Pathogenesis. | J Clin Neurol | 2025 | 40635539 | PubTator, text mining | PubMed |
| Case Report: long-term clinical outcomes in RANBP2-associated acute necrotizing encephalopathy. | Front Pharmacol | 2025 | 40538544 | PubTator, text mining | PubMed |
| Cargo recognition of Nesprin-2 by the dynein adapter Bicaudal D2 for a nuclear positioning pathway that is important for neuronal migration. | bioRxiv | 2025 | 40475460 | PubTator, text mining | PubMed |
| Dominant spinal muscular atrophy linked mutations in the cargo binding domain of BICD2 result in altered interactomes and dynein hyperactivity. | bioRxiv | 2025 | 40462900 | PubTator, text mining | PubMed |
| Bioprospecting potential genetic biomarkers of gallbladder cancer. | Mol Biol Rep | 2025 | 40439781 | PubTator, text mining | PubMed |
| A SUMO-interacting motif in the guanine nucleotide exchange factor EPAC1 is required for subcellular targeting and function. | J Biol Chem | 2025 | 40412525 | PubTator, text mining | PubMed |
| Epithelioid Inflammatory Myofibroblastic Sarcoma: Case Series With a First Report of CLTC::ALK Fusion in an Aggressive Disease. | Genes Chromosomes Cancer | 2025 | 40386890 | PubTator, text mining | PubMed |
| Interaction networks of SIM-binding groove mutants reveal alternate modes of SUMO binding and profound impact on SUMO conjugation. | Sci Adv | 2025 | 40367183 | PubTator, text mining | PubMed |
| Clofoctol impairs the stemness of gastric cancer and induces TNF-mediated necroptosis by directly binding to RanBP2. | Cell Mol Life Sci | 2025 | 40325218 | PubTator, text mining | PubMed |
| TSPYL5-driven G3BP1 nuclear membrane translocation facilitates p53 cytoplasm sequestration via accelerating RanBP2-mediated p53 sumoylation and nuclear export in neuroblastoma. | Cell Death Dis | 2025 | 40319028 | PubTator, text mining | PubMed |
| Anesthetic Management of a Patient With Acute Necrotizing Encephalopathy Type 1. | Cureus | 2025 | 40291183 | PubTator, text mining | PubMed |
| Nuclear pore complex protein RANBP2 and related SUMOylation in solid malignancies. | Genes Dis | 2025 | 40271196 | PubTator, text mining | PubMed |
| Role of lactylation and immune infiltration in atherosclerosis: novel insights from bioinformatics analyses. | Front Genet | 2025 | 40248193 | PubTator, text mining | PubMed |
| A case report of recurrent acute necrotizing encephalopathy with RANBP2 mutation. | Clin Neurol Neurosurg | 2025 | 40179479 | PubTator, text mining | PubMed |
| Nup358 and Nup153 Facilitate nuclear import of BmNPV nucleocapsids in Bombyx mori cells. | J Invertebr Pathol | 2025 | 40120667 | PubTator, text mining | PubMed |
| WTAP contributes to platinum resistance in high-grade serous ovarian cancer by up-regulating malic acid: insights from liquid chromatography and mass spectrometry analysis. | Cancer Metab | 2025 | 40098185 | PubTator, text mining | PubMed |
| Cargo adaptor identity controls the mechanism and kinetics of dynein activation. | J Biol Chem | 2025 | 40021125 | PubTator, text mining | PubMed |
| Strategies for the Viral Exploitation of Nuclear Pore Transport Pathways. | Viruses | 2025 | 40006906 | PubTator, text mining | PubMed |
| Interplay between the cyclophilin homology domain of RANBP2 and MX2 regulates HIV-1 capsid dependencies on nucleoporins. | mBio | 2025 | 39853118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5903/papers?page=4